Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Nov 05, 2026
TickeronGET DAILY SIGNALS
SCHD vs SDY: Weighing Two Top Dividend ETFs for Steady Income

SCHD vs SDY: Weighing Two Top Dividend ETFs for Steady Income

Key Takeaways

  • SCHD tracks the Dow Jones U.S. Dividend 100 Index with roughly 100 holdings, while SDY tracks the S&P High Yield Dividend Aristocrats Index with about 158 holdings.
  • Cost structure is a major differentiator: SCHD charges a 0.06% expense ratio versus 0.35% for SDY, giving SCHD a significant long-term cost advantage.
  • Sector exposure diverges meaningfully — SCHD skews toward consumer staples, healthcare, and energy, while SDY is more heavily weighted to industrials, consumer staples, and utilities.
  • SCHD applies a multi-factor quality screen (dividend yield, dividend growth, and cash-flow strength), whereas SDY emphasizes longevity by requiring at least 20 consecutive years of dividend increases.
  • Tickeron AI Verdict: SCHD — the AI favors SCHD on the combined basis of cost efficiency, liquidity, and balanced quality-based diversification.

Why These Two Dividend ETFs Stand Out

Dividend-focused investors frequently weigh SCHD and SDY against one another, and for good reason. Both are passively managed U.S. large-cap dividend ETFs targeting reliable income and quality cash-flow generation, yet they pursue that goal through meaningfully different index methodologies. SCHD emphasizes dividend sustainability and financial health, while SDY rewards companies with the longest records of uninterrupted dividend growth. In a market environment where investors are increasingly balancing income needs against interest-rate sensitivity and sector rotation, understanding these structural distinctions — rather than short-term price moves — is essential to making an informed ETF comparison. I also checked this using Tickeron’s AI Screener to see how the two stack up on key metrics.

Understanding SCHD

SCHD is a passively managed ETF that seeks to track the Dow Jones U.S. Dividend 100 Index. Launched in October 2011, the fund holds approximately 100 large-cap U.S. companies selected for their dividend yield, dividend growth, and financial strength, including cash-flow-to-debt and return-on-equity criteria. Its ultra-low expense ratio of 0.06% makes it one of the cheapest dividend ETFs available.

Top holdings include TXN, CVX, PG, KO, and UNH. Sector exposure leans defensive, with consumer staples, healthcare, and energy historically among the largest allocations, alongside a notable technology weight. The fund distributes income quarterly and maintains deep liquidity, supported by tens of billions in assets under management.

Understanding SDY

SDY is a passively managed ETF that tracks the S&P High Yield Dividend Aristocrats Index, which selects companies from the S&P 1500 Composite that have increased dividends for at least 20 consecutive years. Launched in November 2005, the fund holds roughly 158 names and applies a yield-weighting methodology that tilts exposure toward higher-yielding constituents. Its expense ratio is 0.35%.

Leading positions include VZ, ACN, CVX, O, and PEP. Industrials, consumer staples, and utilities form the fund's largest sector allocations, reflecting the aristocrats screen's emphasis on established, slow-growing cash-flow generators. The dividend yield is typically lower than SCHD's, reflecting the heavier utility and industrial mix.

Current Market Context for Dividend Strategies

Both funds operate within the broader large-cap value and dividend-income theme, which has been shaped in recent market cycles by shifting interest-rate expectations and sector rotation. When yields on cash and Treasuries are elevated, higher-yielding equity strategies face competition from fixed income; when rate expectations ease, dividend-paying equities tend to regain favor as income sources. The utility-heavy composition of SDY makes it more rate-sensitive, while SCHD's energy and healthcare tilt links its performance more closely to commodity trends and pharmaceutical earnings cycles. Both funds remain broadly defensive relative to growth-heavy benchmarks, a profile that has attracted risk-conscious income investors.

Performance and Positioning Insights

In recent weeks and months, the relative positioning of these two funds has been driven more by sector allocation than by their shared dividend mandate. SCHD's larger energy and healthcare weights have made its performance sensitive to oil-price swings and patent-cycle developments among top pharmaceutical holdings, while its lower expense ratio and deeper liquidity support tighter tracking and trading efficiency. SDY, by contrast, has carried a more conservative, utility- and industrial-heavy profile with lower volatility characteristics. Over full market cycles, SCHD's quality screen and wider yield have tended to provide stronger total-return momentum, whereas SDY's aristocrats methodology emphasizes dividend durability and slower, steadier compounding. Both exhibit below-market beta, making them structurally lower-risk relative to broad equity indices. From what I see, SCHD's edge becomes clearer when factoring in costs and liquidity over longer horizons.

Exploring AI Tools for ETF Research

I rely on Tickeron’s AI Screener as part of my regular workflow when comparing ETFs like these. It lets me apply technical patterns, fundamentals, and AI-driven signals to quickly surface relevant data across thousands of securities. The tool helps refine views on sector tilts, volatility, and relative strength without manual effort, which proves useful when evaluating income-focused strategies side by side.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SCHD, SDY

Momentum Indicator for SCHD turns positive, indicating new upward trend

SCHD saw its Momentum Indicator move above the 0 level on October 12, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned positive. In 72 of the 82 cases, the stock moved higher in the following days. The odds of a move higher are at 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for SCHD just turned positive on October 09, 2026. Looking at past instances where SCHD's MACD turned positive, the stock continued to rise in 40 of 46 cases over the following month. The odds of a continued upward trend are 87%.

SCHD moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SCHD crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 79%.

Following a +0.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where SCHD advanced for three days, in 266 of 319 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

The Aroon Indicator entered an Uptrend today. In 282 of 364 cases where SCHD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 17 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCHD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.

SCHD broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Notable companies

The most notable companies in this group are Chevron Corp (NYSE:CVX), Coca-Cola Company (NYSE:KO), Procter & Gamble Company (NYSE:PG), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), Home Depot (NYSE:HD), Texas Instruments (NASDAQ:TXN), Amgen (NASDAQ:AMGN), Abbott Laboratories (NYSE:ABT), PepsiCo (NASDAQ:PEP).

Industry description

The investment seeks to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100™ Index. To pursue its goal, the fund generally invests in stocks that are included in the index. The index is designed to measure the performance of high dividend yielding stocks issued by U.S. companies that have a record of consistently paying dividends, selected for fundamental strength relative to their peers, based on financial ratios. The fund will invest at least 90% of its net assets in these stocks.

Market Cap

The average market capitalization across the Schwab US Dividend Equity ETF (SCHD) ETF is 59.06B. The market cap for tickers in the group ranges from 377.02M to 425.59B. CVX holds the highest valuation in this group at 425.59B. The lowest valued company is AMSF at 377.02M.

High and low price notable news

The average weekly price growth across all stocks in the Schwab US Dividend Equity ETF (SCHD) ETF was 3%. For the same ETF, the average monthly price growth was 11%, and the average quarterly price growth was 16%. APAM experienced the highest price growth at 16%, while AMSF experienced the biggest fall at -20%.

Volume

The average weekly volume growth across all stocks in the Schwab US Dividend Equity ETF (SCHD) ETF was 42%. For the same stocks of the ETF, the average monthly volume growth was 32% and the average quarterly volume growth was 23%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 66
P/E Growth Rating: 41
Price Growth Rating: 41
SMR Rating: 42
Profit Risk Rating: 56
Seasonality Score: 10 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category LargeValue

Category
Large Value
Address
Schwab Strategic Trust101 Montgomery StreetSan Francisco
Phone
1-800-435-4000
Web
www.csimfunds.com.
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
BIO shares plunged 10.12% to $251.77 from the previous close of $280.12. The selloff followed first-quarter 2026 earnings that included a $527.1 million net loss driven by a $738.2 million investment impairment.
Shares of DLB plunged 10.74% to $57.25 from the previous close of $64.14 during today's trading session. Primary catalyst: Negative market reaction to Q2 fiscal 2026 earnings results released after market close on April 30, despite beating EPS and revenue estimates.